Abstract
Objective: The current study entails quality by design (QbD) enabled the development of a simple, rapid, sensitive, and cost-effective RP-HPLC method for estimation of Lapatinib ditosylate (LPT) in a newly prepared nano-liposomal formulation which has not been reported earlier.
Methods: The chromatographic factors were screened using a fractional factorial design. A central composite design was employed as a response surface methodology. Mobile phase ratio, flow rate, and wavelength were identified as critical method parameters. To minimize retention time, peak area and theoretical plates were employed as critical analytical attributes. A novel nano-liposomal formulation of LPT was prepared by the film hydration method.
Results: The optimized chromatographic condition was obtained at a mobile phase composition of methanol and 0.05% v/v o-phosphoric acid in water (81:19 v/v), flow rate 0.7 ml/min, and peak detected at wavelength 261 nm using DAD detector. The retention time for Lapatinib was 3.702 min. The developed method was validated as per ICH guidelines ICH Q2 (R1). Linearity (R2= 0.999) was observed in the range of 10-50μg/ml. The limit of detection and limit of quantitation was found to be 0.6309μg/ml and 1.9120μg/ml, respectively. LPT containing liposome formulation assay was found to be 99.03% and %RSD was less than 1%.
Conclusion: The newly developed RP-HPLC method applying the QbD approach was found to be simple, specific, precise, accurate, linear, and rugged, with good recovery of LPT in the nano-liposome formulation in a cost-effective manner. Hence it can be employed for the quantification of LPT in bulk and pharmaceutical formulations.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference43 articles.
1. Beg S, Sharma G, Katare OP, Lohan S, Singh B. Development and validation of a stability-indicating liquid chromatographic method for estimating olmesartan medoxomil using quality by design. J Chromatogr Sci. 2015;53(7):1048-59. doi: 10.1093/chromsci/bmu165, PMID 25583970.
2. The International Conference on Harmonization ICH technical requirements for registration of pharmaceuticals for human use on pharmaceutical. Development. 2009;Q8(R2). https://database.ich.org/sites/default/files/Q8%2 8R2%29%20Guideline.pdf
3. The international Conference on Harmonization ICH technical requirements for registration of pharmaceuticals for human use on quality. Risk Manag. 2005;Q9. https://database.ich.org/sites/default/files/Q9%20Guideline.pdf.
4. The international Conference on Harmonization ICH technical requirements for registration of pharmaceuticals for human use on pharmaceutical quality system; 2008. Available from: https://database.ich.org/sites/default/files/Q10%20Guideline.pdf.
5. Borman P, Nethercote P, Chatfield M, Thompson D, Truman K. The application of quality by design to analytical methods. Pharm Technol. 2007;31:142-52.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献